GLPG

Lakefront Biotherapeutics NV

Contracts

$54.5M

Total Value

Stock Metrics

3.2%

Short % Float

11.2d to cover · Moderate squeeze

22.3%

Inst % Float

10 holders · 2026-06-30

Gilead Sciences In

Top Holder

25.4% of float

44.5M sh

Public Float

36/100

Dilution Score

Medium

Verified regulatory filings & proprietary analysis.

Dilution Risk

36/100

MEDIUM

Inst: 22.31% · Top: Gilead Sciences Inc

Biotech Analytics

JAK Fibrosis Inflammation

7.15

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk36

Clinical Trials0

Short Interest10

Date	Source	Title	Awardee	Value	Score
2023-04-10	usaspending	FA882023C0002	GALAPAGOS FEDERAL SYSTEMS	$54.5M	0.4